The Influence of Radical Prostatectomy on the Expression of Cell-Free MiRNA.

Autor: Konoshenko MY; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia.; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia., Bryzgunova OE; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia.; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia., Lekchnov EA; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia.; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia., Amelina EV; The Center for Technology Transfer and Commercialization, Novosibirsk State University, Novosibirsk 630090, Russia., Yarmoschuk SV; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia., Pak SV; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia., Laktionov PP; E.N. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk 630055, Russia.; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2020 Aug 17; Vol. 10 (8). Date of Electronic Publication: 2020 Aug 17.

Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.

Autor: Bryzgunova OE; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Zaporozhchenko IA; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Lekchnov EA; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Amelina EV; Federal State Autonomous Educational Institution of Higher Education 'Novosibirsk National Research University', Novosibirsk, Russia., Konoshenko MY; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Yarmoschuk SV; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Pashkovskaya OA; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Zheravin AA; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Pak SV; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia., Rykova EY; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.; Novosibirsk State Technical University, Novosibirsk, Russia., Laktionov PP; The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.; The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,'E. Meshalkin National Medical Research Center' of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.

Publikováno v: PloS one [PLoS One] 2019 Apr 10; Vol. 14 (4), pp. e0215003. Date of Electronic Publication: 2019 Apr 10 (Print Publication: 2019).

The DNA-hydrolyzing activity of IgG antibodies from human placenta.

Autor: Lekchnov EA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk, 630090, Russia., Dmitrenok PS; Pacific Institute of Bioorganic Chemistry, Far East Division, Russian Academy of Sciences, Vladivostok, 690022, Russia., Zakharova OD; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk, 630090, Russia., Sedykh SE; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk, 630090, Russia., Buneva VN; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk, 630090, Russia., Nevinsky GA; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk, 630090, Russia. Electronic address: nevinsky@niboch.nsc.ru.

Publikováno v: Placenta [Placenta] 2018 Aug; Vol. 68, pp. 1-8. Date of Electronic Publication: 2018 Jun 18.

[Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms].

Autor: Zaporozhchenko IA; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia., Bryzgunova OE; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Lekchnov EA; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Osipov ID; Novosibirsk State University, Novosibirsk, Russia., Zaripov MM; FSBIH SDMC of FMBA of Russia, Novosibirsk, Russia., Yurchenko YB; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia., Yarmoschuk SV; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Pashkovskaya OA; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Rykova EY; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Zheravin AA; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia., Laktionov PP; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia.

Publikováno v: Biomeditsinskaia khimiia [Biomed Khim] 2018 Jan; Vol. 64 (1), pp. 38-45.

Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients.

Autor: Bryzgunova OE; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Zaripov MM; Dispensary department 2, Novosibirsk Regional Oncology Center, Novosibirsk, Russian Federation., Skvortsova TE; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Lekchnov EA; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Grigor'eva AE; Group of microscopy, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Zaporozhchenko IA; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Morozkin ES; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation.; Centre of Oncology and Radiotherapy, Novosibirsk Research Institute of Circulation Pathology Academician E.N. Meshalkin, Novosibirsk, Russian Federation., Ryabchikova EI; Group of microscopy, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Yurchenko YB; Center of New Medical Technologies of ICBFM SB RAS, Novosibirsk, Russian Federation., Voitsitskiy VE; Dispensary department 2, Novosibirsk Regional Oncology Center, Novosibirsk, Russian Federation., Laktionov PP; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation.; Centre of Oncology and Radiotherapy, Novosibirsk Research Institute of Circulation Pathology Academician E.N. Meshalkin, Novosibirsk, Russian Federation.

Publikováno v: PloS one [PLoS One] 2016 Jun 15; Vol. 11 (6), pp. e0157566. Date of Electronic Publication: 2016 Jun 15 (Print Publication: 2016).